Chk2 activation and phosphorylation-dependent oligomerization

Molecular and Cellular Biology

Volumn 22, Issue 12, 2002, Pages 4419-4432

  Xu, Xingzhi ^a   Tsvetkov, Lyuben M ^a   Stern, David F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; GENE PRODUCT; OLIGOMER; UNCLASSIFIED DRUG; WORTMANNIN;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPHOSPHORYLATION; CHIMERA; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; GAMMA IRRADIATION; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ANIMALS; BINDING SITES; CELL CYCLE PROTEINS; CELL-FREE SYSTEM; CELLS, CULTURED; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FIBROBLASTS; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RABBITS; RADIATION, IONIZING; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA;

EID: 0036258583     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.12.4419-4432.2002     Document Type: Article

References (67)

1. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation
2. The nuclear serine/threonine protein kinase DNA-PK
3. Enhanced phosphorylation of p53 by ATM in response to DNA damage
4. Three-dimensional structure of the Stat3beta homodimer bound to DNA
5. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
6. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase
7. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage
8. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
9. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase
10. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
11. Chk2/ hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
12. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
13. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA
14. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity
15. ATR and ATRIP: Partners in checkpoint signaling
16. Requirement of ATM-dependent phosphorylation of brca1 response to double-strand breaks
17. STATs and gene regulation
18. The FHA domain is a modular phosphopeptide recognition motif Mol
19. The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms
20. MECl-dependent phosphorylation of Rad9p in response to DNA damage
21. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
22. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine
23. Cell cycle control and cancer
24. Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer
25. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
26. The FHA domain: A putative nuclear signalling domain found in protein kinases and transcription factors
27. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias
28. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis
29. Cancer risk and the ATM gene: A continuing debate
30. Substrate specificities and identification of putative substrates of ATM kinase family members
31. Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms
32. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation
33. hCds1-mediated phosphoralation of BRCA1 regulates the DNA damage response
34. The FHA domain mediates phosphoprotein interactions
35. Kinase interaction domain of kinase-associated protein phosphatase, a phosphoprotein-binding domain
36. Structure and function of a new phosphopeptide-binding domain containing the FHA2 of Rad53
37. Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9
38. Accounting for specificity in receptor tyrosine kinase signaling
39. Controlling TGF-beta signaling
40. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
41. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
42. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1
43. Two checkpoint complexes are independently recruited to sites of DNA damage in vivo
44. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors
45. Activation of Rad53 kinase in response to DNA damage and its effect in modulating phosphorylation of the lagging strand DNA polymerase
46. Structural basis of Smad1 activation by receptor kinase phosphorylation
47. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways
48. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine
49. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin
50. Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint
51. Autophosphorylation restrains the apoptotic activity of DRP-1 kinase by controlling dimerization and calmodulin binding
52. Structural insights on Smad function in TGFbeta signaling
53. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
54. Screening hCHK2 for mutations
55. Controlling signal transduction with synthetic ligands
56. Interaction of a protein phosphatase with an Arabidopsis serine-threonine receptor kinase
57. Spk1/Rad53 is regulated by Mecl-dependent protein phosphorylation in DNA replication and damage checkpoint pathways
58. Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint
59. CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition
60. The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1-dependent hyperphosphorylation and interacts with Rad53 after DNA damage
61. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks
62. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling
63. Characterization of tumor-associated Chk2 mutations
64. Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues
65. Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity
66. The DNA damage response: Putting checkpoints in perspective
67. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin